Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Short term Debt (2018 - 2024)

Orthofix Medical (OFIX) has disclosed Short term Debt for 10 consecutive years, with $6.2 million as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Short term Debt changed N/A year-over-year to $6.2 million, compared with a TTM value of $6.2 million through Sep 2024, changed N/A, and an annual FY2023 reading of $1.2 million, up 25.0% over the prior year.
  • Short term Debt was $6.2 million for Q3 2024 at Orthofix Medical, up from $4.7 million in the prior quarter.
  • Across five years, Short term Debt topped out at $17.2 million in Q4 2021 and bottomed at $1.0 million in Q4 2022.
  • Average Short term Debt over 5 years is $6.9 million, with a median of $4.7 million recorded in 2024.
  • The sharpest move saw Short term Debt plummeted 94.19% in 2022, then grew 25.0% in 2023.
  • Year by year, Short term Debt stood at $14.9 million in 2020, then rose by 15.44% to $17.2 million in 2021, then tumbled by 94.19% to $1.0 million in 2022, then increased by 25.0% to $1.2 million in 2023, then surged by 400.0% to $6.2 million in 2024.
  • Business Quant data shows Short term Debt for OFIX at $6.2 million in Q3 2024, $4.7 million in Q2 2024, and $3.1 million in Q1 2024.